Literature DB >> 19515520

Glucose transporter type 1 deficiency: ketogenic diet in three patients with atypical phenotype.

Pierangelo Veggiotti1, Federica Teutonico, Enrico Alfei, Nardo Nardocci, Giovanna Zorzi, Anna Tagliabue, Valentina De Giorgis, Umberto Balottin.   

Abstract

Glucose transporter type I deficiency syndrome (GLUT-1 DS) is an inborn error of glucose transport characterized by seizures, developmental delay, spasticity, acquired microcephaly and ataxia. Diagnosis is based on the finding of low cerebrospinal fluid glucose, in the absence of hypoglycemia, and identification of GLUT-1 gene mutation on chromosome 1. The classic phenotype is a severe form of early onset epileptic encephalopathy, but patient with different clinical presentation have been reported expanding the clinical spectrum. In particular, many patients show a prominent movement disorder other than epilepsy. It is known that this disease represents a treatable condition and ketogenic diet (KD) is the elective treatment in GLUT-1 DS patients. We report on KD in three unrelated Italian GLUT-1 DS female patients, diagnosed in early adulthood, all presenting with an atypical phenotype. Preliminary results seem to demonstrate efficacy of KD on paroxysmal movement disorder while positive effect on cognitive impairment result less evident. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515520     DOI: 10.1016/j.braindev.2009.04.013

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

1.  Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome.

Authors:  Pierangelo Veggiotti; Valentina De Giorgis
Journal:  Curr Treat Options Neurol       Date:  2014-05       Impact factor: 3.598

2.  Dystonic tremor caused by mutation of the glucose transporter gene GLUT1.

Authors:  Anne Roubergue; Emmanuelle Apartis; Valérie Mesnage; Diane Doummar; Jean-Marc Trocello; Emmanuel Roze; Guillaume Taieb; Thierry Billette De Villemeur; Sandrine Vuillaumier-Barrot; Marie Vidailhet; Richard Levy
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

Review 3.  Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy.

Authors:  Jing-Qiong Kang
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

4.  Overall cognitive profiles in patients with GLUT1 Deficiency Syndrome.

Authors:  Valentina De Giorgis; Silvia Masnada; Costanza Varesio; Matteo A Chiappedi; Martina Zanaboni; Ludovica Pasca; Melissa Filippini; Joyce A Macasaet; Marialuisa Valente; Cinzia Ferraris; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Brain Behav       Date:  2019-02-04       Impact factor: 2.708

5.  The use of ketogenic diet in special situations: expanding use in intractable epilepsy and other neurologic disorders.

Authors:  Munhyang Lee
Journal:  Korean J Pediatr       Date:  2012-09-14

Review 6.  Potential therapeutic use of the ketogenic diet in autism spectrum disorders.

Authors:  Eleonora Napoli; Nadia Dueñas; Cecilia Giulivi
Journal:  Front Pediatr       Date:  2014-06-30       Impact factor: 3.418

Review 7.  Ketogenic diet in neuromuscular and neurodegenerative diseases.

Authors:  Antonio Paoli; Antonino Bianco; Ernesto Damiani; Gerardo Bosco
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

Review 8.  GLUT1 Deficiency Syndrome-Early Treatment Maintains Cognitive Development? (Literature Review and Case Report).

Authors:  Ivana Kolic; Jelena Radic Nisevic; Inge Vlasic Cicvaric; Ivona Butorac Ahel; Kristina Lah Tomulic; Silvije Segulja; Kristina Baraba Dekanic; Senada Serifi; Aleksandar Ovuka; Igor Prpic
Journal:  Genes (Basel)       Date:  2021-08-31       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.